Carnegie Capital Asset Management, LLC Invitae Corp Transaction History

Carnegie Capital Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$2.13 - $9.01 $14,910 - $63,070	7,000 Added 63.64%	18,000 $607,000
Q1 2022 Apr 11, 2022	SELL	$6.28 - $15.59 $18,840 - $46,770	-3,000 Reduced 21.43%	11,000 $88,000
Q4 2021 Jan 21, 2022	SELL	$14.7 - $28.67 $88,200 - $172,020	-6,000 Reduced 30.0%	14,000 $214,000
Q3 2021 Oct 08, 2021	BUY	$24.31 - $33.6 $48,620 - $67,200	2,000 Added 11.11%	20,000 $569,000
Q2 2021 Jul 16, 2021	SELL	$26.09 - $40.4 $70,443 - $109,080	-2,700 Reduced 13.04%	18,000 $607,000
Q1 2021 Apr 12, 2021	BUY	$33.06 - $56.93 $181,830 - $313,115	5,500 Added 36.18%	20,700 $791,000
Q4 2020 Feb 08, 2021	BUY	$39.09 - $57.4 $78,180 - $114,800	2,000 Added 15.15%	15,200 $636,000
Q3 2020 Oct 13, 2020	BUY	$28.43 - $44.67 $375,276 - $589,644	13,200 New	13,200 $572,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.